Poster, Podium & Video Sessions
Presentation Authors: Kyung Hwa Choi, Byeong Seong Ki, Seung Ryeol Lee, Young Kwon Hong, Dong Soo Park*, Dong Ryul Lee, Seongnam, Korea, Republic of
Introduction: To investigated the efficacy of newly developed human testicular stromal cell (TSC) and neuronal precursor cell (NPC) for erectile function in a mouse model of cavernous nerve crushed injury (CNI)
Methods: Twelve-week-old NOD-SCID mice were divided into eight groups: sham operation group, bilateral CNI group receiving a single intracavernous injection of phosphate-buffered saline (20 μL), TSC1 (3 × 105 cells/20 μL) or TSC2 (6 × 105 cells/20 μL), NPC1 (3 × 105 cells/20 μL) or NPC2 (6 × 105 cells/20 μL), TSC+NPC combination(3 × 105 cells, each, in total 20 μL), ADMSC2 (6 × 105 cells/20 μL) or oral sildenafil group (5mg/kg). Two weeks after CNI and treatment, erectile function was measured by electrically stimulating the cavernous nerve. The penis was harvested for histologic examinations and Western blot analysis. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at our institution.
Results: Significant improvement in erectile function was observed in the TSC2 and TSC+ NPC group which reached 29.8% and 38.1% of the sham control value, respectively (p<0.05). Both in immunohistochemistry and Western blot analysis, TSC2 and TSC+NPC group showed significantly increased expression of cavernous endothelial (PECAM-1, eNOS) and smooth muscle content (α-SMA). NPC2 and TSC+NPC group showed significantly increased expression of neurofilament content in the cavernosum tissue or dorsal nerve bundle (Neurofilament). TSC+NPC combination group showed significant recovery in both functional and molecular levels compared with the single cell treated group. Also the TSC+ NPC combination showed superior results than ADMSC2 or Sildenafil groups.
Conclusions: This is the first study to investigate the efficacy of newly developed TSC and NPC for erectile dysfunction in CNI mouse model. The combination of TSC and NPC successfully restored erectile function in CNI mice by restoring endothelial, smooth muscle, and neuronal content.
Source Of Funding: Basic Science Research Program (Young Researcher Program) through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning((NRF-2015R1C1A1A02037466)
Urology Bundang CHA Medical Center
Bachelor of Medicine Yonsei University College of Medicine, Seoul, Korea
Master of Medicine Yonsei University College of Medicine, Seoul, Korea
Doctor of Medicine Yonsei University College of Medicine, Seoul, Korea
Internship, Residency and Fellowship in Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Short term Post-doctoral training in Mayo Clinic, Rochester, MN, USA (Surgical treatment for Urological cancer)
Long term Post-doctoral training in M.D.Anderson Cancer Center, Houston, TX, USA (Chemotheraphy for Urological cancer)
Long term Post-doctoral training in University of Iowa, Iowa City, IA, USA (IL-2 Immunotherapy for kidney cancer, melanoma)
Short term observership, Memorial Sloan Kettering Cancer Center, New York, NY, USA (Brachytherapy for Prostate cancer)
“Marquis Who’s who” listing since the year 2000
Journal of Urology, Int J Urol, Int Braz J Urol, international Journal of Cancer, Canadian Journal of Urology, Cancer Biomarkers,
Saturday, May 13
3:30 PM – 5:30 PM